...
首页> 外文期刊>Research journal of pharmacy and technology >A Prospective Study on assessment of Quality of Prescribing in Patients with Hypertension using Prescription Quality Index (Pqi) Tool in a Tertiary Care Hospital
【24h】

A Prospective Study on assessment of Quality of Prescribing in Patients with Hypertension using Prescription Quality Index (Pqi) Tool in a Tertiary Care Hospital

机译:高血压患者处方质量指数(PQI)工具在第三级护理医院方面的质量评估预期研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objectives: To determine the Quality of Prescribing in Patients with Hypertension using Prescription Quality Index (PQI) Tool. Ensure the Rational Use of Anti-Hypertensive drugs. Methods: Prospective study of Anti-Hypertensive drugs should be conducted on 150 consecutive patients admitted in tertiary care Hospital. The duration of the study will be of 10 months. The prescriptions of the patient who are treated during the course of the study will be audited prospectively using a specially designed form to record the required information. Results: Total of 150 patients 86 were male and 64 were female.This study the age group who receive more Anti Hypertensive drugs are between 56-65 years(40%), In this study who are found with single comorbid condition is (41.3%), Multiple comorbid condition is (22.7%), In This study stages of Hypertension was validated, Pre Hypertensive (88%),Stage l(57.3%),Stage 2 (34.7%). In This study different classes of drugs commonly used were Diuretics (72%).In the present study it was observed that the higher rates of (56.7%) received dual therapy for Hypertension than mono therapy (43.3%) and compared. Conclusion: Angiotensin II receptor blockers (ARBs) are more effective in slowing the progression of chronic kidney disease (CKD) than other antihypertensive regimens. The PQI is a comprehensive tool which is valid and reliable for measuring quality of prescribing in chronic disease like hypertension in Indian settings. PQI can be used for assessment and comparison of quality of prescribing in different clinical settings at different health care levels.
机译:目标:使用处方质量指数(PQI)工具确定高血压患者处方质量。确保合理使用抗高血压药物。方法:在第三节护理医院承认的150名患者中,应在抗高血压药物前瞻性研究。研究的持续时间为10个月。在研究过程中待遇的患者的处方将使用专门设计的表格进行审核以记录所需信息。结果:共有150例患者86例雄性,64例为女性。该研究在56-65岁(40%)之间,该研究中的年龄组是患者(40%)(41.3%)(41.3%) ),多种同血症条件是(22.7%),在这项研究阶段的高血压验证,预血压(88%),阶段L(57.3%),第2阶段(34.7%)。在这项研究中,常用的不同类别的药物是利尿剂(72%)。在本研究中,观察到较高的(56.7%)接受高血压的双重治疗的速率(56.7%)比单疗法(43.3%)。结论:血管紧张素II受体阻滞剂(ARB)在减缓慢性肾病(CKD)的进展方面比其他抗高血压方案更有效。 PQI是一种综合工具,可有效可靠,可用于测量印度环境中高血压等高血压等慢性疾病的质量。 PQI可用于评估和比较不同医疗水平不同临床环境中规定的质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号